Tolvaptan in autosomal dominant polycystic kidney disease.

Benzazepines/therapeutic use; Female; Humans; Kidney/pathology; Male; Polycystic Kidney, Autosomal Dominant/drug therapy; Receptors, Vasopressin/antagonists & inhibitors

Disciplines :

Urology & nephrology

Author, co-author :

JOURET, François ; Centre Hospitalier Universitaire de Liège - CHU > Néphrologie

Krzesinski, Jean-Marie ; Université de Liège - ULiège > Département des sciences cliniques > Néphrologie

Language :

English

Title :

Tolvaptan in autosomal dominant polycystic kidney disease.

Publication date :

2013

Journal title :

New England Journal of Medicine

ISSN :

0028-4793

eISSN :

1533-4406

Publisher :

Massachusetts Medical Society, United States - Massachusetts

Volume :

368

Issue :

Pages :

1258-9

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 17 April 2013

Statistics

Number of views

174 (21 by ULiège)

Number of downloads

706 (12 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations